News
Research and Markets: The Pharmaceutical Market: Malta 2013
8 May 2013
Our in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the ...
Click on the link to read the full article at Business Wire (press release) (This link will open in a new window)Japanese Pharmaceutical Industry Reviewed by GBI Research in In-Demand ...
7 May 2013
Japan's pharmaceutical industry, the world's second largest, was worth USD 89 billion in 2011, representing 10 per cent of the global market share. However, the industry growth has been hindered by biennial drug price cuts in the recent past. Price ...
Click on the link to read the full article at Wall Street Journal (This link will open in a new window)Fear Of The Unknown-A Persistent Challenge For Biotechnology - SpyGhana.com
7 May 2013
The fear that biotechnology crops or genetic modified crops pose adverse health effects without scientific evidence remains a big challenge to adoption and acceptance of the technology which has high ability to addressing global food insecurity. The ...
Click on the link to read the full article at spyghana.com (This link will open in a new window)Portola Pharmaceutical sets targets for $127M IPO
7 May 2013
Drug development startup Portola Pharmaceuticals Inc. set the price range Tuesday for its upcoming initial public offering in which it hopes to raise up to $127 million. The South San Francisco startup led by CEO William Lis said it plans to sell 6.9 ...
Click on the link to read the full article at Silicon Valley Business Journal (This link will open in a new window)Plandai Biotechnology, Inc. Announces Formation Of New Entity To Develop ...
7 May 2013
SEATTLE, May 7, 2013 /PRNewswire/ -- Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced the formation of Phyto ...
Click on the link to read the full article at PR Newswire (press release) (This link will open in a new window)Glenmark buoyed by speciality, generics businesses
7 May 2013
Drug-maker Glenmark said that its specialty drugs and generics businesses performed well in the year ended March 2013. ?The US, India and Russia businesses continued to maintain its high growth trajectory,? said Glenn Saldanha, Chairman and Managing ...
Click on the link to read the full article at Hindu Business Line (This link will open in a new window)GSK pharmaceutical partnership to help patients 'do more, feel better, live ...
7 May 2013
TAIPEI, Taiwan -- The National Research Program of Biopharmaceuticals (NRPB) and GlaxoSmithKline (GSK) yesterday signed a memorandum of understanding, marking the beginning of a five-year partnership to promote and develop Taiwan as the ...
Click on the link to read the full article at China Post (This link will open in a new window)Plandai Biotechnology signs with Willows Ingredients to expand sales into ...
7 May 2013
In Washington State, Plandai Biotechnology announced an agreement under which Willows Ingredients, Ltd. of Ireland will distribute Plandai's Phytofare extracts into European markets. Targeted industries included in the agreement are the medical, ...
Click on the link to read the full article at Biobased Digest (This link will open in a new window)Look beyond generics profits for income, Alliance chiefs warn
7 May 2013
Furthermore, Pharmacists play a very key and important role in deflating prices of generics through competitive forces, on behalf of the NHS. The NHS realise this, and unless they move to a system of centralised purchasing, then they will continue to ...
Click on the link to read the full article at Chemist+Druggist (This link will open in a new window)Malawi to save $36m on drug imports with Crown Pharmaceuticals establishment
7 May 2013
Malawi is poised to save $36 million annually from drug imports after the establishment of Crown Pharmaceuticals and Research Laboratories Limited, the Ministry of Industry and Trade has said. Principal Secretary for Ministry of Trade and Industry ...
Click on the link to read the full article at Nyasa Times (This link will open in a new window)
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
